Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-09

FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved the generic version of fluphenazine hydrochloride (Amneal) through an original ANDA, for the treatment of schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine hydrochloride (Fluphenazine hydrochloride)

Snippet

ORIG AP for FLUPHENAZINE HYDROCHLORIDE (FLUPHENAZINE HYDROCHLORIDE)